These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7745024)

  • 1. Effects of stimulatory and inhibitory thyrotropin receptor antibodies on lipolysis in infant adipocytes.
    Janson A; Karlsson FA; Micha-Johansson G; Bolme P; Brönnegård M; Marcus C
    J Clin Endocrinol Metab; 1995 May; 80(5):1712-6. PubMed ID: 7745024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipolytic effects of thyrotropin and isoprenaline are not affected by growth hormone in infant adipocytes.
    Janson A; Marcus C
    Horm Metab Res; 1997 Apr; 29(4):164-7. PubMed ID: 9178024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin.
    Bahn RS; Dutton CM; Joba W; Heufelder AE
    Thyroid; 1998 Feb; 8(2):193-6. PubMed ID: 9510130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific knockout of TSHr in white adipose tissue increases adipocyte size and decreases TSH-induced lipolysis.
    Elgadi A; Zemack H; Marcus C; Norgren S
    Biochem Biophys Res Commun; 2010 Mar; 393(3):526-30. PubMed ID: 20152797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of thyrotropin receptor in infant adipocytes.
    Janson A; Rawet H; Perbeck L; Marcus C
    Pediatr Res; 1998 Apr; 43(4 Pt 1):555-8. PubMed ID: 9545014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor.
    Sanders J; Oda Y; Roberts S; Kiddie A; Richards T; Bolton J; McGrath V; Walters S; Jaskólski D; Furmaniak J; Smith BR
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3797-802. PubMed ID: 10523032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.
    Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
    Hidaka A; Okajima F; Ban T; Kosugi S; Kondo Y; Kohn LD
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1164-9. PubMed ID: 8077307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system.
    Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies.
    Latrofa F; Chazenbalk GD; Pichurin P; Chen CR; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4734-45. PubMed ID: 15356088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human thyrotropin (TSH) receptor in a TSH binding inhibition assay for TSH receptor autoantibodies.
    Kakinuma A; Chazenbalk GD; Jaume JC; Rapoport B; McLachlan SM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2129-34. PubMed ID: 9215283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
    Brokken LJ; Wiersinga WM; Prummel MF
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the functional extracellular domain of human thyrotropin receptor using a vaccinia virus system: its purification and analysis of autoantibody binding.
    Lee MH; Park JY; Cho BY; Chae CB
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1391-7. PubMed ID: 10199784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.